Claudia Trojaniello

3PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Mar 30, 2023
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned.

Claudia Trojaniello, Francesca Sparano, Eleonora Cioli

|Feb 24, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Domenico Mallardo, Ester Simeone, Lucia Festino

Pageof 1

Frequent Collaborators

2 joint publications

Mariaelena Capone

2 joint publications

Paolo Antonio Ascierto

1 joint publications

Domenico Mallardo

1 joint publications

Ester Simeone